Market Credibility

To provide a solid value story for investors, peers, health care providers, payers and patients, Decision Driver Analytics performs comprehensive and definitive product value analysis when: (1) the results of pivotal clinical studies become available; (2) post-market outcomes and economic studies have been performed; or (3) the product has been in the marketplace long enough for payer claims data to be available, permitting claims data analysis.

Unlike our predictive models, which are for internal use, these models are prepared to establish the validity of your claims in the marketplace. They are detailed, footnoted and cross-referenced and are therefore highly suitable for publication in professional journals or as white papers. By publishing this information, you increase your credibility and establish your expertise in the marketplace.

  • Payer and provider data mining and analysis
  • Definitive product analysis models disseminated as:
    • Peer-reviewed journal articles
    • White papers
  • Clinical-economic payer dossiers
  • Interactive budgetary impact or return-on-investment models for health care facilities
  • Interactive cost-effectiveness or cost-benefit models for payers

 

RESOURCES

Quantitative Assessment of Hard Surface Disinfection Activity Against the Food-Borne Pathogen, Listeria Monocytogenes
2006
April Zambelli-Wiener, Ph.D.
Topics: PHARMACOLOGY / DISINFECTANTS / DRUG EFFECTS / FOOD MICROBIOLOGY / PATHOGENS

Economic Evaluation of Lamivudine Compared With Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States
2001
Elizabeth Brooks, Ph.D.
Topics: HEPATITIS B / ANTIVIRAL AGENTS / BUDGETS / COST-BENEFIT ANALYSIS / LAMIVUDINE

Injectable Collagen and a Rare Adverse Event – True Association or Artifact?
1998
Roseanne B. McTyre, Ph.D.
Topics: BIOMATERIALS / MEDICAL DEVICES / INJECTABLE COLLAGEN

View more resources